Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-24

Clinical Trial Update: Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the effect of combining lapaquistat acetate with fenofibrate on blood cholesterol levels in patients with hyperlipidemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)
  • Lapaquistat Acetate (lapaquistat acetate)

Snippet

Sponsor: Takeda | Conditions: Hyperlipidemias | Phase 2 | Status: COMPLETED